Since the activation of the ETB receptor has a vasodilating effect, unlike the ETA receptor, ETB-selective agonists have been studied as vasodilator drugs for the improvement of tumour drug delivery, as well as for the treatment of hypertension2,3. This evidence concerns the gene EDNRB and neoplasm.